Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial
A legfontosabb adatok
- Ki végzi
- University of New Mexico
- Hol
- Albuquerque és Ann Arbor (Egyesült Államok)Mind a 2 helyszín megnézése
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 160 fő, tervezett
- Kezdés
- 2023. máj. 5.
- Várható befejezés
- 2026. dec. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP)
- Enhance Usual Care (EUC)
- A regiszteradat frissítve
- 2026. október 30.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 8 feltétel megnézéseKevesebb
Ki vehet részt
- Stabilized on a dose of buprenorphine for a period of at least 1 month. Buprenorphine stabilization will be defined as a consistent dose for at least 30 consecutive days
- Willing to comply with all study procedures and be available for the duration of the study
- Aged 18 years or older
- Enrolled as a patient in one of the participating clinics
- Presence of chronic pain for > 6 months in duration
Ki nem vehet részt
- Current or past diagnosis of schizophrenia, delusional disorder, psychotic or dissociative disorders
- Have a substance use disorder requiring a higher level of care than outpatient treatment (e.g., severe alcohol use disorder requiring inpatient detoxification)
- Unable to read English
Helyszínek itt: Egyesült Államok
- University of New MexicoAlbuquerque, Egyesült Államok
- University of MichiganAnn Arbor, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study is a multisite randomized clinical trial of a treatment designed to reduce pain interference while simultaneously addressing relapse prevention among individuals who have co-occurring chronic pain and Opioid Use Disorder (OUD). This study will recruit approximately 160 individuals who are currently being treated in clinics specializing in the physician management of OUD. To increase generalizability of study findings and increase internal validity of the physician management component of treatment, all participants will be stabilized on buprenorphine for OUD as part of their usual clinical care. Individuals will be randomized to either: (1) enhanced usual care or (2) the integrated ACT + MBRP treatment. The investigators hypothesize that: (1) the combination of ACT + MBRP in buprenorphine-prescribed patients with chronic pain will be more efficacious across primary and secondary outcome measures in comparison to Enhanced Usual Care and (2) examination of treatment mechanism data will indicate treatment-related changes that are consistent with the theoretical models of ACT+MBRP.
A vizsgálat 2 csoportja
- ACT + MBRP InterventionA vizsgált kezelés
The ACT + MBRP group will follow a manualized clinical protocol. Treatment will include 12 weekly, virtual group-based sessions, each lasting 90 minutes. Group sizes will range from three to ten participants. All sessions will be audio recorded for fidelity. Over the course of the group meetings, participants identify areas of meaningful functioning that have been adversely impacted by pain, learn methods to enhance pain willingness in the service of these meaningful areas, and practice present-focused awareness skills. Group sessions include discussions of the impact of pain and distress avoidance, identifying alternatives to this avoidance and establishing plans for behavior change, demonstration and role-playing exercises, and homework assignments. Participants are provided with a treatment manual to help guide and inform practice outside of group sessions.
Kezelés: Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP)
- Enhanced Usual Care (EUC)Már használt kezelés, összehasonlításként
The Enhanced Usual Care (EUC) condition will supplement standard practices within the study sites related to chronic pain and OUD education. Participants randomized to the EUC condition will receive a brochure (in-person, via email, or via text message) with a list of chronic pain treatment resources, signs and management of opioid overdose including naloxone, and overdose prevention, and will encouraged to schedule an appointment with a clinical provider if they would like to discuss any current or past symptoms. In addition to receiving the brochure, EUC condition participants will meet with a therapist remotely for approximately 15 minutes for a descriptive overview of the brochure. In this session, the therapist will point out the resources in the brochure and read the helpful tips out loud to the participant. This session will be audio recorded for fidelity.
Kezelés: Enhance Usual Care (EUC)
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Integrative Treatment for Achieving Holistic Recovery From Comorbid Chronic Pain and Opioid Use Disorder
- Publikációk
- A regiszteradat frissítve
- 2026. október 30.